Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Duy T, Nguyen"'
Autor:
Megan Kunkel, BS, Peter Rothstein, MD, Peter Sauer, Matthew M. Zipse, MD, Amneet Sandhu, MS, MD, Alexis Z. Tumolo, MD, Ryan T. Borne, MD, Ryan G. Aleong, MD, Joseph C. Cleveland, Jr., MD, David Fullerton, MD, Jay D. Pal, MD, PhD, Austin S. Davies, BS, Curtis Lane, BS, Duy T. Nguyen, MD, FHRS, William H. Sauer, MD, FHRS, Wendy S. Tzou, MD, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 3, Pp 271-279 (2021)
Background: Ventricular tachycardia (VT) catheter ablation success may be limited when transcutaneous epicardial access is contraindicated. Surgical ablation (SurgAbl) is an option, but ablation guidance is limited without simultaneously acquired ele
Externí odkaz:
https://doaj.org/article/abaca59f2f9f41429993ed3930e38ed4
Autor:
Anas Al Bastami, Alexander Jurkov, David Otten, Duy T. Nguyen, Aaron Radomski, David J. Perreault
Publikováno v:
IEEE Open Journal of Power Electronics, Vol 1, Pp 124-138 (2020)
Dynamically-tunable impedance matching is a key feature in numerous radio-frequency (RF) applications at high frequencies (10 s of MHz) and power levels (100s-1000 s of Watts and above). This work develops techniques that enable the design of high po
Externí odkaz:
https://doaj.org/article/0bae8343c49546dd9a3086fb0d48f3b8
Autor:
Duy T. Nguyen, Elizabeth Ogando-Rivas, Ruixuan Liu, Theodore Wang, Jacob Rubin, Linchun Jin, Haipeng Tao, William W. Sawyer, Hector R. Mendez-Gomez, Matthew Cascio, Duane A. Mitchell, Jianping Huang, W. Gregory Sawyer, Elias J. Sayour, Paul Castillo
Publikováno v:
Cells, Vol 11, Iss 12, p 1974 (2022)
The promising outcomes of chimeric antigen receptor (CAR) T cell therapy in hematologic malignancies potentiates its capability in the fight against many cancers. Nevertheless, this immunotherapy modality needs significant improvements for the treatm
Externí odkaz:
https://doaj.org/article/7ccd12e916a543e9999556664a8c4baa
Autor:
Duy T. Nguyen, Jack E. Famiglietti, Ryan A. Smolchek, Zadia Dupee, Nickolas Diodati, Diego I. Pedro, Juan M. Urueña, Matthew A. Schaller, W. Gregory Sawyer
Publikováno v:
Cells, Vol 11, Iss 6, p 967 (2022)
Existing 3D cell models and technologies have offered tools to elevate cell culture to a more physiologically relevant dimension. One mechanism to maintain cells cultured in 3D is by means of perfusion. However, existing perfusion technologies for ce
Externí odkaz:
https://doaj.org/article/5124565ffa6740ba9d0c4a89c36997b1
Autor:
Amneet Sandhu, Blair Holman, Steven Lammers, Lukasz Cerbin, Christopher Barrett, Rafay Sabzwari, Lohit Garg, Matthew M. Zipse, Alexis Z. Tumolo, Ryan G. Aleong, Johannes Von Alvensleben, Michael Rosenberg, John J. West, Paul Varosy, Duy T. Nguyen, William H. Sauer, Wendy S. Tzou
Publikováno v:
Journal of Cardiovascular Electrophysiology. 34:880-887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05264205ff2611bc5308981c0c7619b6
https://doi.org/10.1111/jce.15826
https://doi.org/10.1111/jce.15826
Autor:
Duy T. Nguyen, Kenneth C. Bilchick, Sanjiv M. Narayan, Mina K. Chung, Kevin L. Thomas, Kenneth R. Laurita, Marmar Vaseghi, Roopinder Sandhu, Mihail G. Chelu, Prince J. Kannankeril, Douglas L. Packer, David D. McManus, Atul Verma, Matthew Singleton, Khaldoun Tarakji, Sana M. Al-Khatib, Jonathan R. Kaltman, Ravi C. Balijepalli, George F. Van Hare, Jodie L. Hurwitz, Andrea M. Russo, Fred M. Kusumoto, Christine M. Albert
Publikováno v:
Heart Rhythm. 19:1927-1945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca97578508558be840f127dd1cc6d5c5
https://doi.org/10.1016/j.hrthm.2022.08.004
https://doi.org/10.1016/j.hrthm.2022.08.004
Autor:
Duy T. Nguyen, Wei Yang, Arun Renganathan, Cody Weimholt, Duminduni H. Angappulige, Thanh Nguyen, Robert W. Sprung, Gerald L. Andriole, Eric H. Kim, Nupam P. Mahajan, Kiran Mahajan
Publikováno v:
Clin Cancer Res
Purpose: Androgen receptor (AR) antagonism is exacerbated by HOXB13 in castration-resistant prostate cancers (CRPC). However, it is unclear when and how HOXB13 primes CRPCs for AR antagonism. By mass-spectrometry analysis of CRPC extract, we uncovere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f63004ae596807ca9cbc8293255fed56
https://doi.org/10.1158/1078-0432.ccr-21-3603
https://doi.org/10.1158/1078-0432.ccr-21-3603
Autor:
William H. Sauer, Nathaniel A. Steiger, Wendy S. Tzou, Joseph L. Schuller, Lijun Zheng, Duy T. Nguyen
Publikováno v:
JACC: Clinical Electrophysiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fd9a0c6908e70cb0ae85577f57aad47
https://doi.org/10.1016/j.jacep.2023.02.025
https://doi.org/10.1016/j.jacep.2023.02.025
Autor:
Kiran Mahajan, Ernst Schonbrunn, Nicholas J. Lawrence, Ranjan Perera, Youngchul Kim, Uwe Rix, Subramaniam Shymalagovindarajan, Jingsong Zhang, Jasreman Dhillon, Domenico Coppola, Anthony M. Magliocco, John Puskas, Norbert Berndt, Rezaul M. Karim, Steven Gunawan, Yunyun Chen, Neha Agarwal, Brent M. Kuenzi, Muhammad Ayaz, Harshani R. Lawrence, Alexey M. Eroshkin, Ami K. Patel, Duy T. Nguyen, Jiqiang Yao, Niveditha Nerlakanti
Supplementary Fig. 1. Epigenetic landscape and the transcription cofactor recruitment at the HOXB13 enhancer region under various treatments; Supplementary Figure 2. BRD4 is a target of the dual BET-kinase inhibitors in CRPCs; Supplementary Figure 3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9532fee211fdd48d8b5145a41ce0a4
https://doi.org/10.1158/1535-7163.22504905.v1
https://doi.org/10.1158/1535-7163.22504905.v1
Autor:
Kiran Mahajan, Ernst Schonbrunn, Nicholas J. Lawrence, Ranjan Perera, Youngchul Kim, Uwe Rix, Subramaniam Shymalagovindarajan, Jingsong Zhang, Jasreman Dhillon, Domenico Coppola, Anthony M. Magliocco, John Puskas, Norbert Berndt, Rezaul M. Karim, Steven Gunawan, Yunyun Chen, Neha Agarwal, Brent M. Kuenzi, Muhammad Ayaz, Harshani R. Lawrence, Alexey M. Eroshkin, Ami K. Patel, Duy T. Nguyen, Jiqiang Yao, Niveditha Nerlakanti
Supplementary Table 1: Table provides information on the siRNA sequences and/or chemical structures of the non-FDA approved inhibitors for bromodomain proteins, transcription factors and kinases described in the current study. Supplementary Table 2:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce2b2dd01ae32a0980a741719a0d9f3
https://doi.org/10.1158/1535-7163.22504902.v1
https://doi.org/10.1158/1535-7163.22504902.v1